Cargando…
Biomarkers of the Endocannabinoid System in Substance Use Disorders
Despite substance use disorders (SUD) being one of the leading causes of disability and mortality globally, available therapeutic approaches remain ineffective. The difficulty in accurately characterizing the neurobiological mechanisms involved with a purely qualitative diagnosis is an obstacle to i...
Autores principales: | Navarrete, Francisco, García-Gutiérrez, María S., Gasparyan, Ani, Navarro, Daniela, López-Picón, Francisco, Morcuende, Álvaro, Femenía, Teresa, Manzanares, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946268/ https://www.ncbi.nlm.nih.gov/pubmed/35327588 http://dx.doi.org/10.3390/biom12030396 |
Ejemplares similares
-
Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
por: García-Gutiérrez, María Salud, et al.
Publicado: (2022) -
Inflammatory Biomarkers in Addictive Disorders
por: Morcuende, Alvaro, et al.
Publicado: (2021) -
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021) -
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020) -
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
por: Navarro, Daniela, et al.
Publicado: (2022)